NIIMBL Announces $10M for 8 New Biopharmaceutical Manufactur

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $10M in planned project...

Related Keywords

California , United States , Texas , University Of Houston , New Jersey , Newark , Santa Clara University , Los Angeles , Sartorius Stedim , Chris Roberts , Bristol Myers Squibb , John Balchunas , Daniel Maiese , University Of Massachusetts Lowell , Serono , Batavia Biosciences Inc , Chromatan Corporation , Janssen Research Development , National Institute Of Standards , Enzene Biosciences Ltd , Genentech , Pfizer Inc , Institute Project Call , Technology Enables Truly Continuous , Rensselaer Polytechnic Institute , Institute Director , University Of California , Adcs For Process Development , Virica Biotech Inc , Us Department Of Commerce , Lonza Biologics Inc , Enquyst Technologies Inc , Continuous Countercurrent Tangential Chromatography Technology , National Institute For Innovation , Global Health Fund , University Of New Jersey , Astrazeneca , Carnegie Mellon University , Merck Sharp Dohme , National Institute , Manufacturing Biopharmaceuticals , Project Call , Associate Institute , Process Intensification , Batavia Biosciences , Antibody Mix And Read Assays Based , Fluorescence Intensity , Small Molecule Formulations , Enhanced Production , Virica Biotech , Commercial Deployment , Enable Continuous Upstream Production , Glycosylated Monoclonal , State University , Hauser Optical Analysis , Process Development , Rensselaer Polytechnic , Isoelectric Point Purification , End To Chromatography Free Manufacturing , Yield Ultra High Purity , Enquyst Technologies , Lonza Biologics , Neurodiverse Talent Pipeline , Janssen Research , Santa Clara , Biocom California , Merck Sharp , Manufacturing United States ,